Stallard, N
185  Ergebnisse:
Personensuche X
?
1

Evidence-informed recommendations on managing breast screen..:

Freeman, K ; Mansbridge, A ; Stobart, H...
https://eprints.whiterose.ac.uk/209293/1/tqad053.pdf.  , 2024
 
?
2

Statistical analysis plan for the motor neuron disease syst..:

Parker, RA ; Weir, CJ ; Pham, TM...
https://discovery.ucl.ac.uk/id/eprint/10163985/1/Statistical%20analysis%20plan%20for%20the%20motor%20neuron%20disease%20systematic%20multi-arm%20adaptive%20randomised%20trial%20%28MND-SMART%29.pdf.  , 2023
 
?
5

Statistical consideration when adding new arms to ongoing c..:

Lee, KM ; Brown, LC ; Jaki, T..
https://discovery.ucl.ac.uk/id/eprint/10125031/1/s13063-021-05150-7.pdf.  , 2021
 
?
6

Clinical trials in amyotrophic lateral sclerosis: a systema..:

Wong, C ; Stavrou, M ; Elliott, E...
https://openaccess.sgul.ac.uk/id/eprint/114915/1/fcab242.pdf.  , 2021
 
?
7

Clinical trials in amyotrophic lateral sclerosis: a systema..:

Wong, C ; Stavrou, M ; Elliott, E...
https://discovery.ucl.ac.uk/id/eprint/10141618/1/Clinical%20trials%20in%20amyotrophic%20lateral%20sclerosis%20a%20systematic%20review%20and%20perspective.pdf.  , 2021
 
?
8

Amiloride, fluoxetine or riluzole to reduce brain volume lo..:

De Angelis, F ; Connick, P ; Parker, RA...
https://discovery.ucl.ac.uk/id/eprint/10098411/1/3032522.pdf.  , 2020
 
?
9

Efficacy of three neuroprotective drugs in secondary progre..:

Chataway, J ; De Angelis, F ; Connick, P...
https://eprints.whiterose.ac.uk/156388/8/PIIS1474442219304855.pdf.  , 2020
 
?
10

Efficacy of three neuroprotective drugs in secondary progre..:

Chataway J ; De Angelis F ; Connick P...
info:eu-repo/semantics/altIdentifier/pmid/31981516.  , 2020
 
?
11

Amiloride, Fluoxetine or Riluzole to Reduce Brain Volume Lo..:

De Angelis F ; Connick P ; Parker RA...
info:eu-repo/semantics/altIdentifier/pmid/32453521.  , 2020
 
?
12

Efficacy of three neuroprotective drugs in secondary progre..:

Chataway, J ; De Angelis, F ; Connick, P...
https://discovery.ucl.ac.uk/id/eprint/10090747/1/Braisher_Efficacy%20of%20three%20neuroprotective%20drugs%20in%20secondary%20progressive%20multiple%20sclerosis_AOP.pdf.  , 2020
 
1-15